Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 251 entries
View as:

Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01668797 Org: User:
Start: 10/31/12 End: 02/28/15 Due: 02/28/16

The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy Use

Phase: N/A Priority: Normal
NCT ID: NCT01141400 Org: User:
Start: 06/30/09 End: 10/31/10 Due: 10/31/11

Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT02547428 Org: User:
Start: 08/03/15 End: 06/04/16 Due: 06/04/17

A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.

Phase: N/A Priority: Normal
NCT ID: NCT04369391 Org: User:
Start: 06/18/20 End: 11/10/20 Due: 11/10/21

A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Phase: N/A Priority: Normal
NCT ID: NCT04786574 Org: User:
Start: 07/01/22 End: 10/11/27 Due: 10/11/28

EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan

Phase: N/A Priority: Normal
NCT ID: NCT00071331 Org: User:
Start: 09/30/03 End: 07/31/06 Due: 07/31/07

Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB

Phase: N/A Priority: Normal
NCT ID: NCT05221502 Org: User:
Start: 04/12/22 End: 05/19/24 Due: 05/19/25

Aripiprazole and Effexor XR Drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT00362271 Org: User:
Start: 08/31/06 End: 09/30/06 Due: 09/30/07

A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT04109950 Org: User:
Start: 11/20/19 End: 11/09/23 Due: 11/09/24

A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03854409 Org: User:
Start: 01/31/19 End: 02/20/20 Due: 02/20/21

Schizophrenia Trial of Aripiprazole

Phase: N/A Priority: Normal
NCT ID: NCT00237913 Org: User:
Start: 07/31/04 End: 08/31/05 Due: 08/31/06

A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.

Phase: N/A Priority: Normal
NCT ID: NCT04115319 Org: User:
Start: 11/15/19 End: 12/30/22 Due: 12/30/23

Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD

Phase: N/A Priority: Normal
NCT ID: NCT01210560 Org: User:
Start: 10/31/10 End: 06/30/11 Due: 06/30/12

Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01289080 Org: User:
Start: 01/31/11 End: 01/31/12 Due: 01/31/13

Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)

Phase: N/A Priority: Normal
NCT ID: NCT01360632 Org: User:
Start: 06/30/11 End: 09/30/13 Due: 09/30/14

Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress

Phase: N/A Priority: Normal
NCT ID: NCT02196506 Org: User:
Start: 07/31/14 End: 05/31/16 Due: 05/31/17

Study of Rebamipide Eye Drops to Treat Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT00201955 Org: User:
Start: 05/31/04 End: 07/31/06 Due: 07/31/07

A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03257865 Org: User:
Start: 09/19/17 End: 01/22/19 Due: 01/22/20

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01111565 Org: User:
Start: 10/04/10 End: 09/01/11 Due: 09/01/12

Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole

Phase: N/A Priority: Normal
NCT ID: NCT02219009 Org: User:
Start: 08/31/14 End: 07/31/15 Due: 07/31/16

A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication

Phase: N/A Priority: Normal
NCT ID: NCT05628103 Org: User:
Start: 12/19/22 End: 04/01/24 Due: 04/01/25

Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability

Phase: N/A Priority: Normal
NCT ID: NCT02212613 Org: User:
Start: 09/30/14 End: 11/30/15 Due: 11/30/16

Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02411695 Org: User:
Start: 03/31/15 End: 01/31/17 Due: 01/31/18

A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT03678688 Org: User:
Start: 10/18/18 End: 03/11/22 Due: 03/11/23

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

Phase: N/A Priority: Normal
NCT ID: NCT01859923 Org: User:
Start: 07/20/13 End: 01/13/20 Due: 01/13/21